Łukasz Opaliński

1.9k total citations
57 papers, 1.4k citations indexed

About

Łukasz Opaliński is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Łukasz Opaliński has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 23 papers in Cell Biology and 14 papers in Immunology. Recurrent topics in Łukasz Opaliński's work include Fibroblast Growth Factor Research (29 papers), Proteoglycans and glycosaminoglycans research (17 papers) and Galectins and Cancer Biology (10 papers). Łukasz Opaliński is often cited by papers focused on Fibroblast Growth Factor Research (29 papers), Proteoglycans and glycosaminoglycans research (17 papers) and Galectins and Cancer Biology (10 papers). Łukasz Opaliński collaborates with scholars based in Poland, Germany and Netherlands. Łukasz Opaliński's co-authors include Jacek Otlewski, Małgorzata Zakrzewska, Ida J. van der Klei, Marten Veenhuis, Natalia Porębska, Thomas Becker, Chris Williams, Jan A.K.W. Kiel, Nikolaus Pfanner and Lena-Sophie Wenz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Łukasz Opaliński

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Łukasz Opaliński Poland 23 1.2k 265 157 128 119 57 1.4k
Jonathan Clark United Kingdom 19 848 0.7× 405 1.5× 339 2.2× 33 0.3× 151 1.3× 41 1.5k
Lawrence D. Schweitzer United States 9 920 0.8× 309 1.2× 190 1.2× 23 0.2× 121 1.0× 10 1.3k
Laura Rodríguez de la Ballina Norway 12 455 0.4× 149 0.6× 99 0.6× 51 0.4× 134 1.1× 18 848
Lars Israel Germany 21 990 0.8× 212 0.8× 75 0.5× 106 0.8× 169 1.4× 28 1.5k
Miroslav Nikolov Germany 14 921 0.8× 80 0.3× 65 0.4× 80 0.6× 71 0.6× 19 1.1k
Sachin Katyal Canada 19 1.6k 1.3× 126 0.5× 71 0.5× 45 0.4× 463 3.9× 35 1.8k
Ningguo Gao United States 20 1.0k 0.8× 458 1.7× 310 2.0× 24 0.2× 80 0.7× 30 1.5k
Suryakiran Vadrevu United States 15 621 0.5× 288 1.1× 88 0.6× 13 0.1× 82 0.7× 18 1.0k
Troy A. A. Harkness Canada 19 1.2k 1.0× 164 0.6× 36 0.2× 30 0.2× 106 0.9× 49 1.4k

Countries citing papers authored by Łukasz Opaliński

Since Specialization
Citations

This map shows the geographic impact of Łukasz Opaliński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Łukasz Opaliński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Łukasz Opaliński more than expected).

Fields of papers citing papers by Łukasz Opaliński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Łukasz Opaliński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Łukasz Opaliński. The network helps show where Łukasz Opaliński may publish in the future.

Co-authorship network of co-authors of Łukasz Opaliński

This figure shows the co-authorship network connecting the top 25 collaborators of Łukasz Opaliński. A scholar is included among the top collaborators of Łukasz Opaliński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Łukasz Opaliński. Łukasz Opaliński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krowarsch, Daniel, et al.. (2025). Production and purification of recombinant long protein isoforms of FGF11 subfamily. Journal of Biotechnology. 403. 9–16. 1 indexed citations
2.
Krowarsch, Daniel, et al.. (2024). Uncovering key steps in FGF12 cellular release reveals a common mechanism for unconventional FGF protein secretion. Cellular and Molecular Life Sciences. 81(1). 356–356. 2 indexed citations
3.
Zakrzewska, Małgorzata, et al.. (2024). The intracellular interplay between galectin-1 and FGF12 in the assembly of ribosome biogenesis complex. Cell Communication and Signaling. 22(1). 175–175.
4.
Krowarsch, Daniel, et al.. (2023). FGF12: biology and function. Differentiation. 139. 100740–100740. 6 indexed citations
5.
Czyrek, Aleksandra, et al.. (2023). FGF homologous factors are secreted from cells to induce FGFR ‐mediated anti‐apoptotic response. The FASEB Journal. 37(7). e23043–e23043. 12 indexed citations
6.
Porębska, Natalia, et al.. (2023). Targeting HER2 and FGFR-positive cancer cells with a bispecific cytotoxic conjugate combining anti-HER2 Affibody and FGF2. International Journal of Biological Macromolecules. 254(Pt 1). 127657–127657. 6 indexed citations
7.
Porębska, Natalia, Aleksandra Czyrek, Daniel Krowarsch, et al.. (2023). Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling. Cell Communication and Signaling. 21(1). 122–122. 6 indexed citations
8.
Gebert, Magdalena, Sylwia Bartoszewska, Łukasz Opaliński, James F. Collawn, & Rafał Bartoszewski. (2023). IRE1-mediated degradation of pre-miR-301a promotes apoptosis through upregulation of GADD45A. Cell Communication and Signaling. 21(1). 322–322. 13 indexed citations
9.
Porębska, Natalia, et al.. (2023). Multivalent protein-drug conjugates – An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells. Biotechnology Advances. 67. 108213–108213. 18 indexed citations
10.
Opaliński, Łukasz, et al.. (2022). Cyclic and dimeric fibroblast growth factor 2 variants with high biomedical potential. International Journal of Biological Macromolecules. 218. 243–258. 7 indexed citations
11.
Opaliński, Łukasz, et al.. (2022). FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex. Cell Communication and Signaling. 20(1). 182–182. 17 indexed citations
12.
Porębska, Natalia, et al.. (2021). Galectins as modulators of receptor tyrosine kinases signaling in health and disease. Cytokine & Growth Factor Reviews. 60. 89–106. 34 indexed citations
13.
Doan, Kim Nguyen, Christoph U. Mårtensson, Lars Ellenrieder, et al.. (2020). The Mitochondrial Import Complex MIM Functions as Main Translocase for α-Helical Outer Membrane Proteins. Cell Reports. 31(4). 107567–107567. 61 indexed citations
14.
Szlachcic, Anna, Aleksandra Czyrek, Łukasz Opaliński, et al.. (2019). Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity. Cells. 8(8). 899–899. 9 indexed citations
15.
Opaliński, Łukasz, et al.. (2018). High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1. International Journal of Molecular Sciences. 19(5). 1435–1435. 28 indexed citations
16.
Opaliński, Łukasz, Jiyao Song, Chantal Priesnitz, et al.. (2018). Recruitment of Cytosolic J-Proteins by TOM Receptors Promotes Mitochondrial Protein Biogenesis. Cell Reports. 25(8). 2036–2043.e5. 68 indexed citations
17.
Opaliński, Łukasz, et al.. (2017). The autoinhibitory function of D1 domain of FGFR1 goes beyond the inhibition of ligand binding. The International Journal of Biochemistry & Cell Biology. 89. 193–198. 12 indexed citations
18.
Ellenrieder, Lars, Łukasz Opaliński, Lars Becker, et al.. (2016). Separating mitochondrial protein assembly and endoplasmic reticulum tethering by selective coupling of Mdm10. Nature Communications. 7(1). 13021–13021. 67 indexed citations
19.
Wenz, Lena-Sophie, Łukasz Opaliński, Nils Wiedemann, & Thomas Becker. (2015). Cooperation of protein machineries in mitochondrial protein sorting. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(5). 1119–1129. 25 indexed citations
20.
Opaliński, Łukasz, et al.. (2011). The significance of peroxisomes in secondary metabolite biosynthesis in filamentous fungi. Biotechnology Letters. 33(10). 1921–1931. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026